Integrating dynamic contrast-enhanced magnetic resonance imaging and diffusion kurtosis imaging for neoadjuvant chemotherapy assessment in nasopharyngeal carcinoma
Dechun Zheng1, Yunbin Chen1, Meng Liu1, Qiuyuan Yue1, Xiaoxiao Zhang1, Hao Lin1, Xiangyi Liu1, Wang Ren1, Weibo Chen2, and Queenie Chan3

1Radiology, Fujian Provincial Cancer Hospital, Fuzhou, China, People's Republic of, 2Philips Healthcare, Shanghai, China, People's Republic of, 3Philips Healthcare, Hong Kong, Hong Kong

Synopsis

DKI is an emerging technique and shows advantage than traditional DWI. Prior DCE-MRI studies suggested it had utility in early monitoring radiotherapy and chemotherapy sensitivity in anti-tumor treatment. However, there are a few studies investigated whether a combination of multi-modalities functional MRI techniques could improve diagnostic efficacy for prediction of anti-tumor outcome. This study enrolled 53 patients who received both DCE-MRI and DKI exams during NAC courses and suggested there were collaboration between DCE-MRI and DKI to early monitor NAC treatments in NPC. In addition, two NAC cycles is a better time point to non-invasive assess NAC response using fMRI.

Abstract

Purpose Dynamic contrast-enhanced MRI (DCE MRI) had been proved valuable to ultra-early predict neoadjuvant chemotherapy (NAC) response in nasopharyngeal carcinoma (NPC) 1. Another study suggested that diffusion parameters derived from Non-Gaussian model might reveal additional tissue properties of NPC as compared with mono-exponential model 2 and we recently found that diffusion kurtosis imaging (DKI) was valuable for predicting NAC response in NPC 3. The purpose of this study was to determine the value of combining DCE MRI and DKI in early monitoring NAC response in NPC.

Materials and Methods Fifty-three newly diagnosed locally advanced NPC patients received four MRI exams using a 3.0 T Philips MRI system (Achieva TX, Best, the Netherlands) before and on the 4th, 20th and 40th days after NAC initiation prospectively. DKI with 4 b-values (0, 500, 1000, and 1500 mm2/sec) were applied. The DCE MRI parameters derived from extended Tofts’ model (including Ktrans [the volume transfer constant of Gd-DTPA], Κep [flux rate constant], νe [the extracellular volume fraction of the imaged tissue], and νp [the blood volume fraction]) and DKI parameters (including D [corrected diffusion coefficient] and K [excess diffusion kurtosis coefficient]) were calculated from Philips software developed in IDL 6.3 (ITT Visual Information Solutions, Boulder, CO). Parameters and their corresponding changes Δparameter(0-X) (X = 4, 20 or 40 days) were compared between responders and non-responders after one or two NAC cycles using independent student T test or Mann-Whitney U test followed by logistic regression and receiver operating characteristic curve (ROC) analyses.

Results Among 53 enrolled NPC patients, 15 and 24 subjects were categorized into responders group (RG) after one and two NAC cycles respectively. Compared to non-responders group (NRG), RG patients after either one or two NAC cycles presented significantly higher mean Ktrans and D values at baseline and larger ΔKtrans(0-4), Δvp(0-4) and ΔD(0-4) values (all P values <0.05). Moreover, Kep and ΔKep(0-4) proved significantly larger (P <0.05) in RG than in NRG grouped by response after two NAC cycles but did not after one NAC cycle. For the above parameters, ROC analyses demonstrated that combined DCE-MRI and DKI model gained higher diagnosis accuracy to distinguish non-responders from responders than using either alone both after one (0.857 vs 0.749 or 0.812, Fig. 1) and two (0.987 vs 0.872 or 0.897, Fig. 2) NAC cycles.

Discussions The DKI and DCE MRI derived parameters could reflect physiological features and pathologic changes (diffusion and angiogenesis) at the micron level1,4 and corresponding changes after therapy1,3. In this pilot study, a combination of DKI and DCE MRI was explored and proved that a higher diagnosis accuracy was obtained in early predicting NAC response in NPC. The value of multi-parameters MRI in grading glioma had been validated recently5. This study demonstrate the application of multi-parameters MRI for NAC assessment in NPC was encouraging.

Conclusions Both DCE MRI and DKI demonstrated a trend toward higher diagnostic accuracy to early assess two cycles than one cycle NAC treatment in NPC. Combining DCE-MRI and DKI modalities gained higher accuracy for both assessing one and two NAC treatment than either model was used independently.

Acknowledgements

This study is partly supported by the Natural Science Foundation of Fujian Province (Grant No. 2012J01330) and partly supported by the National Clinical Key Specialty Construction Program and Key Clinical Specialty Discipline Construction Program of Fujian, P.R.C.

References

1. Zheng DC, et al. J Magn Reson Imaging. 2015; 41(6):1528-40.

2. Yuan J, et al. PloS one. 2014; 9(1):e87024.

3. Chen Y, et al. J Magn Reson Imaging. 2015; 42(5):1354-61.

4. Raab P, et al. Radiology. 2010; 254(3):876-881.

5. Van Cauter S, et al. Neuro Oncol. 2014;16(7):1010-21.

Figures

The diagnostic accuracy of the different MRI model in predicting the responses to one (Fig.1) or two (Fig.2) NAC in NPC patients were formed and displayed. In both figure, we could found that the combination of DCE MRI and DKI model (red line) gained higher sensitivity and specificity than using DCE MRI (green line) or DKI (blue line) alone.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
2649